International Forum of Allergy & Rhinology
Scope & Guideline
Advancing Knowledge in Allergy and Rhinology
Introduction
Aims and Scopes
- Chronic Rhinosinusitis Research:
The journal consistently publishes studies that explore various aspects of chronic rhinosinusitis (CRS), including its pathophysiology, treatment modalities, and the role of biologics in management. - Allergic Rhinitis and Immunotherapy:
There is a strong focus on allergic rhinitis, including studies on immunotherapy, novel treatment approaches, and the impact of environmental factors on allergic responses. - Olfactory Dysfunction Studies:
Research on olfactory dysfunction, particularly as it relates to chronic conditions and post-viral syndromes, is a core area of interest, with an emphasis on diagnostic and therapeutic advancements. - Surgical Innovations in Rhinology:
The journal highlights advancements in surgical techniques for sinus and nasal procedures, including endoscopic surgeries, and their outcomes, reflecting a commitment to improving surgical care. - Epidemiological and Health Disparities Research:
There is a notable interest in studies that examine the epidemiology of rhinological conditions and the impact of socioeconomic factors on patient outcomes. - Utilization of Artificial Intelligence and Machine Learning:
Recent publications indicate an emerging trend towards the use of AI and machine learning in diagnostics and treatment planning within rhinology, showcasing innovative methodologies.
Trending and Emerging
- Impact of COVID-19 on Olfactory Function:
There is a significant increase in research exploring the effects of COVID-19 on olfactory dysfunction, highlighting the pandemic's lasting impact on rhinology. - Biologics and Targeted Therapies:
A clear trend towards the exploration of biologics and targeted therapies for chronic rhinosinusitis and allergic conditions is evident, with numerous studies assessing their efficacy and safety. - Integration of Telemedicine in Rhinology:
The incorporation of telemedicine and digital health solutions in managing rhinological conditions has gained traction, especially in light of the COVID-19 pandemic. - Patient-Centered Outcomes and Quality of Life:
Research focusing on patient-reported outcomes, quality of life assessments, and shared decision-making in treatment plans is increasingly prominent, emphasizing patient engagement. - Environmental and Socioeconomic Factors:
Emerging studies are examining the influence of environmental exposures and socioeconomic determinants on rhinological health, reflecting a broader understanding of health disparities. - Artificial Intelligence in Diagnostics:
The application of AI and machine learning in diagnostic processes and treatment planning is on the rise, signaling a shift towards more technologically advanced methodologies in rhinology.
Declining or Waning
- Traditional Pharmacological Treatments:
There has been a noticeable decrease in studies focused exclusively on traditional pharmacological treatments for sinusitis and allergies, as interest shifts towards biologics and novel therapies. - Basic Science Research:
The volume of purely basic science research related to rhinology is waning, as the journal moves towards more clinical and applied research that directly impacts patient care. - Focus on Historical Perspectives:
Papers providing historical perspectives or reviews of older treatment modalities are becoming less common, as the emphasis is increasingly on contemporary practices and innovations. - Epidemiological Studies without Clinical Application:
Research that presents epidemiological data without clear clinical implications or actionable insights is less frequently featured, prioritizing studies that can directly inform practice.
Similar Journals
Allergy & Rhinology
Advancing knowledge in allergy and respiratory health.Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA
Unveiling New Discoveries in Allergy and Immunological HealthALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.
Current Allergy & Clinical Immunology
Exploring breakthroughs in allergic condition treatments.Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.
AIMS Allergy and Immunology
Advancing the Frontiers of Allergy and ImmunologyAIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.
Alergologia Polska-Polish Journal of Allergology
Exploring the frontiers of allergic disease management.Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Connecting researchers to the latest in immunological advancements.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.
Current Treatment Options in Allergy
Advancing Allergy Care Through Innovative ResearchCurrent Treatment Options in Allergy is an esteemed academic journal published by SpringerNature, focusing on a critical area of health science: the evolving landscape of allergy treatments. With an E-ISSN of 2196-3053, this journal aims to provide a comprehensive platform for researchers and practitioners in the fields of Immunology and Allergy and Medicine. It has garnered recognition in the academic community, reflecting its significant contribution with a Q3 ranking in Immunology and Allergy and a Q3 ranking in Medicine as of 2023. The journal is based in Switzerland and encompasses research spanning from 2014 to 2024, ensuring that the latest findings and treatment options are available to professionals and students alike. With a growing focus on open access, it aims to make critical allergy treatment research widely accessible, thus fostering innovation and collaboration in this vital health sector. As the prevalence of allergies continues to rise globally, Current Treatment Options in Allergy plays a crucial role in disseminating important research and treatment strategies to improve patient outcomes.
Current Opinion in Allergy and Clinical Immunology
Bridging research and clinical excellence in allergy care.Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.
RHINOLOGY
Leading the way in sinus health advancements.RHINOLOGY is a premier journal dedicated to the field of otorhinolaryngology, published by the International Rhinologic Society. With a notable impact factor reflecting its standing in the academic community, RHINOLOGY ranks in the Q1 quartile for both Medicine (miscellaneous) and Otorhinolaryngology, placing it among the top-tier journals in the field. Since its inception in 1973, this biannual publication has served as a vital resource for researchers, clinicians, and students, covering a broad range of topics related to nasal and sinus disorders, their pathophysiology, diagnosis, and treatment. The journal's commitment to disseminating high-quality research ensures that it remains at the forefront of advancements in rhinology, making it an essential platform for those seeking to contribute to and stay informed about critical developments in this ever-evolving discipline. The journal operates under a traditional subscription model, providing access to its valuable content primarily through academic libraries and institutions.
Allergo Journal
Advancing knowledge in Immunology and Allergy.Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.